查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
藥物發現服務市場：趨勢、機遇、競爭分析 [2023-2028]
市場調查報告書
商品編碼
1285024

藥物發現服務市場：趨勢、機遇、競爭分析 [2023-2028]

Drug Discovery Services Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

藥物發現服務市場趨勢與預測

到 2028 年，全球藥物發現服務市場預計將達到 373 億美元，2023 年至 2028 年的複合年增長率為 14.1%。 該市場的主要驅動力是由於各種疾病病例數量的增加而導致對藥物發現服務的需求不斷增加、最終用戶對專業測試服務的需求不斷增加以及對不明藥物的研究活動不斷增加。 在未來的全球藥物發現服務市場中，我們可以期待製藥和生物技術公司以及學術機構市場的商機。

藥物發現服務公司名單

市場上的公司根據其提供的產品質量進行競爭。 該市場的主要參與者專注於擴大製造設施、投資研發、升級基礎設施以及利用整個價值鏈的整合機會。 這些策略使藥物發現服務公司能夠滿足不斷增長的需求、確保競爭優勢、開發創新產品和技術、降低製造成本並擴大客戶群。

藥物發現服務市場洞察

  • Lucintel 預計，由於小分子外包項目的增加以及學術機構、生物技術公司和大型製藥公司越來越多地採用，化學服務將在預測期內成為最大的細分市場。我預計這一趨勢將維持不變。
  • 此外，由於老年人慢性病的增加以及製藥和生物製藥公司對新藥開發的興趣日益濃厚，預計製藥公司和生物技術公司將繼續成為最大的細分市場。
  • 由於製藥公司和生物企業對研發活動的積極投資、使用先進設施進行持續的藥物發現研究以及主要 CRO 的存在，北美地區在預測期內將繼續增長。預計將成為最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1.您的細分市場中最有前途和高增長的機會是什麼？
  • Q.2.哪些領域將以更快的速度增長？為什麼？
  • Q.3.您認為哪些地區的增長速度會更快？為什麼？
  • Q.4.影響市場動態的關鍵因素有哪些？ 這個市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的業務風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.這個市場中的客戶需求有哪些變化？
  • Q.8.市場有哪些新發展？ 哪些公司正在引領這些發展？
  • Q.9.這個市場的主要參與者是誰？ 主要參與者採取哪些戰略舉措來發展業務？
  • Q.10.該市場上的競爭產品有哪些？因材料或產品替代而導致市場份額損失的威脅是什麼？
  • 問題 11.過去五年發生了哪些併購以及它們對行業產生了哪些影響？

內容

第 1 章執行摘要

第 2 章全球藥物發現服務市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 行業驅動因素和挑戰

第三章2017-2028年市場趨勢及預測分析

  • 宏觀經濟趨勢（2017-2022 年）和預測（2023-2028 年）
  • 全球藥物發現服務市場趨勢（2017-2022 年）和預測（2023-2028 年）
  • 按流程劃分的全球藥物發現服務市場
    • 目標選擇
    • 目標驗證
    • H2L 的識別
    • 閱讀優化
    • 候選人驗證
  • 按類型劃分的全球藥物發現服務市場
    • 化學服務
    • 生物服務
  • 按藥物類型劃分的全球藥物發現服務市場
    • 小分子藥物
    • 生物製藥
  • 按治療領域劃分的全球藥物發現服務市場
    • 腫瘤
    • 神經病學
    • 心血管疾病
    • 呼吸系統疾病
    • 糖尿病和其他治療領域
  • 按最終用戶劃分的全球藥物發現服務市場
    • 製藥和生物技術公司
    • 學術機構
    • 其他

第四章2017-2028年分地區市場趨勢及預測分析

  • 按地區劃分的藥物發現服務市場
  • 北美的藥物發現服務市場
  • 歐洲藥物發現服務市場
  • 亞太藥物發現服務市場
  • 其他區域藥物發現服務市場

第五章競爭分析

  • 產品組合分析
  • 業務整合
  • 波特五力分析

第 6 章增長機會和戰略分析

  • 增長機會分析
    • 按流程劃分的全球藥物發現服務市場增長機會
    • 按類型劃分的全球藥物發現服務市場增長機會
    • 按藥物類型劃分的全球藥物發現服務市場增長機會
    • 按治療領域劃分的全球藥物發現服務市場的增長機會
    • 最終用戶的全球藥物發現服務市場增長機會
    • 按地區劃分的全球藥物發現服務市場增長機會
  • 全球藥物發現服務市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球藥物發現服務市場的容量
    • 全球藥物發現服務市場的合併、收購和合資企業
    • 身份驗證和許可

第 7 章主要公司簡介

  • Eurofins Scientific
  • Evotec SE
  • Charles River Laboratories International
  • GenScript
  • Thermo Fisher Scientific
  • Oncodesign Services
  • ChemPartner Co.
  • DiscoverX Corp.
  • QIAGEN
  • Domainex Ltd
簡介目錄

Drug Discovery Services Market Trends and Forecast

The future of the global drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets. The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028 with a CAGR of 14.1% from 2023 to 2028. The major drivers for this market are increasing need for drug discovery services with growing cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.

A more than 150-page report is developed to help in your business decisions.

Drug Discovery Services Market by Segment

The study includes a forecast for the global drug discovery services market by process, type, drug type, therapeutic area, end users, and region, as follows:

Drug Discovery Services Market by Process [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Target Selection
  • Target Validation
  • Hit-to-Lead Identification
  • Lead Optimization
  • Candidate Validation

Drug Discovery Services Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Chemistry Services
  • Biology Services

Drug Discovery Services Market by Drug Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Small-molecule Drugs
  • Biologics

Drug Discovery Services Market by Therapeutic Area [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Oncology
  • Neurology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes and Other Therapeutic Areas

Drug Discovery Services Market by End Users [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Others

Drug Discovery Services Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug Discovery Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery services companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery services companies profiled in this report include.

  • Eurofins Scientific
  • Evotec SE
  • Charles River Laboratories International
  • GenScript
  • Thermo Fisher Scientific
  • Oncodesign Services
  • ChemPartner Co.
  • DiscoverX Corp.
  • QIAGEN
  • Domainex Ltd

Drug Discovery Services Market Insights

  • Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.
  • Within this market, pharmaceutical & biotechnology companies is expected to remain the largest segment due to surge in the number of chronic diseases among the elderly population and growing interest of pharmaceutical and biopharmaceutical companies in developing new drugs.
  • North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.

Features of the Drug Discovery Services Market

  • Market Size Estimates: Drug discovery services market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Drug discovery services market size by various segments, such as by process, type, drug type, therapeutic area, end users, and region
  • Regional Analysis: Drug discovery services market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by process, type, drug type, therapeutic area, end users, and regions for the drug discovery services market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the drug discovery services market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug discovery services market size?

Answer: The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028.

Q2. What is the growth forecast for drug discovery services market?

Answer: The global drug discovery services market is expected to grow with a CAGR of 14.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the drug discovery services market?

Answer: The major drivers for this market are increasing need for drug discovery services with augmenting cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.

Q4. What are the major segments for drug discovery services market?

Answer: The future of the drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets.

Q5. Who are the key drug discovery services companies?

Answer: Some of the key drug discovery services companies are as follows:

  • Eurofins Scientific
  • Evotec SE
  • Charles River Laboratories International
  • GenScript
  • Thermo Fisher Scientific
  • Oncodesign Services
  • ChemPartner Co.
  • DiscoverX Corp.
  • QIAGEN
  • Domainex Ltd

Q6. Which drug discovery services segment will be the largest in future?

Answer:Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.

Q7. In drug discovery services market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1.What are some of the most promising, high-growth opportunities for the drug discovery services market by process (target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation), type (chemistry services and biology services), drug type (small-molecule drugs and biologics), therapeutic area (oncology, neurology, cardiovascular diseases, respiratory diseases, and diabetes and other therapeutic areas), end users (pharmaceutical & biotechnology companies, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

Table of Contents

1. Executive Summary

2. Global Drug Discovery Services Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Drug Discovery Services Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Drug Discovery Services Market by Process
    • 3.3.1: Target Selection
    • 3.3.2: Target Validation
    • 3.3.3: Hit-to-Lead Identification
    • 3.3.4: Lead Optimization
    • 3.3.5: Candidate Validation
  • 3.4: Global Drug Discovery Services Market by Type
    • 3.4.1: Chemistry Services
    • 3.4.2: Biology Services
  • 3.5: Global Drug Discovery Services Market by Drug Type
    • 3.5.1: Small-molecule Drugs
    • 3.5.2: Biologics
  • 3.6: Global Drug Discovery Services Market by Therapeutic Area
    • 3.6.1: Oncology
    • 3.6.2: Neurology
    • 3.6.3: Cardiovascular Diseases
    • 3.6.4: Respiratory Diseases
    • 3.6.5: Diabetes and Other Therapeutic Areas
  • 3.7: Global Drug Discovery Services Market by End Users
    • 3.7.1: Pharmaceutical & Biotechnology Companies
    • 3.7.2: Academic Institutes
    • 3.7.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Drug Discovery Services Market by Region
  • 4.2: North American Drug Discovery Services Market
    • 4.2.1: North American Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.2.2: North American Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
  • 4.3: European Drug Discovery Services Market
    • 4.3.1: European Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.3.2: European Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
  • 4.4: APAC Drug Discovery Services Market
    • 4.4.1: APAC Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.4.2: APAC Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
  • 4.5: ROW Drug Discovery Services Market
    • 4.5.1: ROW Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.5.2: ROW Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug Discovery Services Market by Process
    • 6.1.2: Growth Opportunities for the Global Drug Discovery Services Market by Type
    • 6.1.3: Growth Opportunities for the Global Drug Discovery Services Market by Drug Type
    • 6.1.4: Growth Opportunities for the Global Drug Discovery Services Market by Therapeutic Area
    • 6.1.5: Growth Opportunities for the Global Drug Discovery Services Market by End Users
    • 6.1.6: Growth Opportunities for the Global Drug Discovery Services Market by Region
  • 6.2: Emerging Trends in the Global Drug Discovery Services Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug Discovery Services Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Services Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Eurofins Scientific
  • 7.2: Evotec SE
  • 7.3: Charles River Laboratories International
  • 7.4: GenScript
  • 7.5: Thermo Fisher Scientific
  • 7.6: Oncodesign Services
  • 7.7: ChemPartner Co.
  • 7.8: DiscoverX Corp.
  • 7.9: QIAGEN
  • 7.10: Domainex Ltd